气相色谱法测定医药中间体2-甲氧基-4-氯-5-氟嘧啶含量
摘 要
标 签
Abstract
中图分类号 O657.7
所属栏目 知识与经验
基金项目 江苏出入境检验检疫局科研项目(2007KJ07)
收稿日期 2014/1/9
修改稿日期
网络出版日期
作者单位点击查看
引用该论文: 吴赤斌,舒婕,顾益秋,张爱平. [J]. Physical Testing and Chemical Analysis part B:Chemical Analysis, 2015, 51(1): 122～124
吴赤斌,舒婕,顾益秋,张爱平. 气相色谱法测定医药中间体2-甲氧基-4-氯-5-氟嘧啶含量[J]. 理化检验－化学分册, 2015, 51(1): 122～124
共有人对该论文发表了看法，其中：
人认为该论文很差
人认为该论文较差
人认为该论文一般
人认为该论文较好
人认为该论文很好
参考文献
【1】TASSEL D, MADOFF M A. Treatment of candida sepsis and cryptococcus meningitis with 5-fluorocytosine. A new antifungal agent［J］. J Am Med Assoc, 1968,206(4):830-832.
【2】LYMAN C A, WALSH T J. Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications［J］. Drugs, 1992,44(1):9-35.
【3】VERMESA, GUCHELAAR H J, DANKERT J. Flucytosine: a reviewof its pharmacology, clinical indications, pharmacok-inetics, toxicity and drug interactions［J］. J Antimicrob Chem other, 2000,46(2):171-179.
【4】AKIMOTO M, MIYAHARA T, ARAI J, et al. A new delivery system for 5-fluorouracil using prodrug and converting enzyme［J］. J Ophthalmol, 2002,86(5):581-586.
【5】潘雪,李兆申,许国铭,等.胞嘧啶脱氨酶/5-氟胞嘧啶系统治疗胰腺癌体内实验研究［J］.中华实验外科杂志, 2003,20(2):123-124.
【6】邹华,刘翔,郑亿庆.胞嘧啶转氨酶基因联合5-氟胞嘧啶对喉癌细胞的抑制作用［J］.中国耳鼻咽喉头颈外科, 2006,13(8):531-532.
【2】LYMAN C A, WALSH T J. Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications［J］. Drugs, 1992,44(1):9-35.
【3】VERMESA, GUCHELAAR H J, DANKERT J. Flucytosine: a reviewof its pharmacology, clinical indications, pharmacok-inetics, toxicity and drug interactions［J］. J Antimicrob Chem other, 2000,46(2):171-179.
【4】AKIMOTO M, MIYAHARA T, ARAI J, et al. A new delivery system for 5-fluorouracil using prodrug and converting enzyme［J］. J Ophthalmol, 2002,86(5):581-586.
【5】潘雪,李兆申,许国铭,等.胞嘧啶脱氨酶/5-氟胞嘧啶系统治疗胰腺癌体内实验研究［J］.中华实验外科杂志, 2003,20(2):123-124.
【6】邹华,刘翔,郑亿庆.胞嘧啶转氨酶基因联合5-氟胞嘧啶对喉癌细胞的抑制作用［J］.中国耳鼻咽喉头颈外科, 2006,13(8):531-532.
相关信息
